John has a PhD in molecular pharmacology and brings over a decade of comprehensive laboratory experience, from basic research to all aspects of large molecule bioanalysis. He currently leads scientific and operational oversight of the biomarker and molecular laboratories at Immunologix and plays a pivotal role in maintaining the highest standards of data quality and scientific excellence.

From the initial launch of the biomarker lab in 2018, John has collaborated closely with the leadership team to deliberately develop and build an exceptional facility and partnership model that has become a highly sought after, industry-leading service offering. This achievement underscores John's expertise in biomarker method development and a steadfast commitment to a science-first approach. By leveraging a deep understanding of biomarker science, John ensures program success through close, collaborative partnerships with clients and project teams, from comprehensive project intake and experimental planning through to timely completion of deliverables.

Throughout his career, John has remained dedicated to fostering the growth of future scientists. With a focus on people development and a passion for mentorship, John empowers the next generation of scientists, providing them with knowledge, guidance, and training needed to excel in this dynamic field.

John's contributions are marked by a passion for scientific rigor and a commitment to advancing the field of biomarker analysis. His presence at industry conferences not only showcases his expertise but also strengthens professional relationships and fosters new collaborations. By engaging with clients directly, John demonstrates a commitment to understanding their needs and providing tailored biomarker and bioanalytical solutions. John’s involvement in scientific forums within the community underscores his dedication to sharing insights and advancing knowledge. Through these engagements, John has established himself as a trusted figure within the field.